Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21 - BIOGEN INC. | biib-20151231xex21.htm |
| EX-31.2 - EXHIBIT 31.2 - BIOGEN INC. | biib-20151231xex312.htm |
| EX-31.1 - EXHIBIT 31.1 - BIOGEN INC. | biib-20151231xex311.htm |
| EX-32.1 - EXHIBIT 32.1 - BIOGEN INC. | biib-20151231xex321.htm |
| EX-10.37 - EXHIBIT 10.37 - BIOGEN INC. | biib-20151231xex1037.htm |
| EX-10.23 - EXHIBIT 10.23 - BIOGEN INC. | biib-20151231xex1023.htm |
| EX-10.24 - EXHIBIT 10.24 - BIOGEN INC. | biib-20151231xex1024.htm |
| EX-10.42 - EXHIBIT 10.42 - BIOGEN INC. | biib-20151231xex1042.htm |
| 10-K - 10-K - BIOGEN INC. | biib-20151231x10k.htm |
| EX-10.41 - EXHIBIT 10.41 - BIOGEN INC. | biib-20151231xex1041.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-206799) and Registration Statements on Forms S-8 (Nos. 333-205254, 333-110432, 333-128339, 333-152456, 333-140817 and 333-170133) of Biogen Inc. of our report dated February 3, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 3, 2016